2019
DOI: 10.1007/s12020-019-01886-0
|View full text |Cite
|
Sign up to set email alerts
|

Comparison and preliminary discussion of the reasons for the differences in diagnostic performance and unnecessary FNA biopsies between the ACR TIRADS and 2015 ATA guidelines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
31
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(40 citation statements)
references
References 28 publications
8
31
0
1
Order By: Relevance
“…Although this evidence is based on two studies, these findings concur with some studies that indicated ATA- and KWAK-TIRADS have better diagnostic efficiency in comparison with other TIRADS systems in human visual assessment of thyroid nodules >1 cm [78,79,80]. Contrarily, some recent studies state that ACR-TIRADS has the lowest false-negative rate and is superior at reducing cases of unnecessary thyroid FNAC [81,82,83]. The differences in literature findings may be due to the differences in the criteria within the different TIRADS systems.…”
Section: Discussionsupporting
confidence: 82%
“…Although this evidence is based on two studies, these findings concur with some studies that indicated ATA- and KWAK-TIRADS have better diagnostic efficiency in comparison with other TIRADS systems in human visual assessment of thyroid nodules >1 cm [78,79,80]. Contrarily, some recent studies state that ACR-TIRADS has the lowest false-negative rate and is superior at reducing cases of unnecessary thyroid FNAC [81,82,83]. The differences in literature findings may be due to the differences in the criteria within the different TIRADS systems.…”
Section: Discussionsupporting
confidence: 82%
“…However, multiple studies have found that the ATA guidelines have a higher sensitivity, greater negative predictive value, and similar overall diagnostic performance when compared to the ACR-TIRADS. 29,30 When applying the ATA risk stratification methods in our study, only one patient with malignant final pathology had characteristics consistent with the high suspicion classification, and this classification was not significantly associated with malignancy on regression analysis. Therefore, ultrasound interpretation did not contribute to the reliability of FNAB in this study, highlighting the benefit of incorporating an objective modifier such as age.…”
Section: Discussionmentioning
confidence: 64%
“…A non-significant difference in the rate of detection of thyroid cancer was noted, favoring the ATA guidelines (97% v 91%; P=0.180). As expected, this was due to a lower number of FNAs recommended by TIRADS (482 v 582 for ATA), with a rate of unnecessary FNAs of 23% for ACR-TIRADS and 35% for ATA 108. However, the definition of unnecessary biopsies was based on a benign result; clinically, other factors might justify the need for biopsy.…”
Section: Estimating the Risk Of Thyroid Cancer And Need For Thyroid Bmentioning
confidence: 70%
“…Subsequent studies used a combined assessment of ultrasound features either qualitatively or quantitatively to develop ultrasound risk stratification systems that can estimate the prevalence of malignancy (POM) (table 4 and table 5). 4593949596979899100101102103104105106107108109110111…”
Section: Estimating the Risk Of Thyroid Cancer And Need For Thyroid Bmentioning
confidence: 99%